Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

Background Chimeric antigen receptor (CAR) T-cell therapy shows impressive results in clinical trials. We conducted a meta-analysis based on the most recent data to systematically describe the efficacy and safety of anti-BCMA CAR T therapy for patients with relapsed or refractory multiple myeloma (R...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lina Zhang, Xuxing Shen, Wenjun Yu, Jing Li, Jue Zhang, Run Zhang, Jianyong Li, Lijuan Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2021-01-01
coleção:	Annals of Medicine
Assuntos:	Chimeric antigen receptor T-cell therapy multiple myeloma efficacy safety
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/07853890.2021.1970218
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!